• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA:阿尔茨海默病发病机制中的关键调节因子及精准医学前景

Long Non-Coding RNAs: Crucial Regulators in Alzheimer's Disease Pathogenesis and Prospects for Precision Medicine.

作者信息

Yang Chenbo, Li Yiwei, Chen Chao, Sun Zexin, Liu Enjie, Wei Na, Liu Xiaonan, Shu Jiao, Zhao Na, Sun Miaomiao

机构信息

Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.

Henan Key Laboratory of Tumor Pathology, Zhengzhou University, Zhengzhou, People's Republic of China.

出版信息

Mol Neurobiol. 2025 Jun;62(6):7525-7541. doi: 10.1007/s12035-025-04729-4. Epub 2025 Feb 5.

DOI:10.1007/s12035-025-04729-4
PMID:39907902
Abstract

Long non-coding RNAs (LncRNAs) have emerged as pivotal regulators in the pathogenesis of Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. With the capacity to modulate gene expression at various levels, LncRNAs are implicated in multiple pathological mechanisms of AD, including amyloid-beta (Aβ) accumulation, tau protein phosphorylation, neuroinflammation, and neuronal apoptosis. Recent studies have highlighted the potential of LncRNAs as diagnostic biomarkers and therapeutic targets due to their differential expression patterns in AD patients. This review synthesizes current knowledge on the role of LncRNAs in AD, focusing on their involvement in key molecular pathways and their promise as indicators for early diagnosis and prognosis. We discuss the regulatory networks of LncRNAs in the context of AD, their interaction with miRNAs, and the implications for developing novel therapeutic strategies. Despite the complexity and variability in LncRNA function, the prospect of harnessing these molecules for precision medicine in AD is gaining momentum. The translational potential of LncRNA-based interventions offers a new frontier in the quest for effective treatments and a deeper understanding of the molecular underpinnings of AD.

摘要

长链非编码RNA(LncRNAs)已成为阿尔茨海默病(AD)发病机制中的关键调节因子,AD是一种以认知衰退和记忆丧失为特征的进行性神经退行性疾病。LncRNAs具有在多个水平调节基因表达的能力,参与AD的多种病理机制,包括β淀粉样蛋白(Aβ)积累、tau蛋白磷酸化、神经炎症和神经元凋亡。最近的研究强调了LncRNAs作为诊断生物标志物和治疗靶点的潜力,因为它们在AD患者中具有差异表达模式。这篇综述综合了关于LncRNAs在AD中作用的当前知识,重点关注它们在关键分子途径中的参与情况以及作为早期诊断和预后指标的前景。我们讨论了AD背景下LncRNAs的调控网络、它们与微小RNA(miRNAs)的相互作用以及对开发新型治疗策略的意义。尽管LncRNA功能复杂且多变,但利用这些分子进行AD精准医学的前景正日益受到关注。基于LncRNA的干预措施的转化潜力为寻求有效治疗方法和更深入了解AD的分子基础开辟了新的前沿领域。

相似文献

1
Long Non-Coding RNAs: Crucial Regulators in Alzheimer's Disease Pathogenesis and Prospects for Precision Medicine.长链非编码RNA:阿尔茨海默病发病机制中的关键调节因子及精准医学前景
Mol Neurobiol. 2025 Jun;62(6):7525-7541. doi: 10.1007/s12035-025-04729-4. Epub 2025 Feb 5.
2
Non-coding RNAs in the pathogenesis of Alzheimer's disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation.非编码RNA在阿尔茨海默病发病机制中的作用:β-淀粉样蛋白聚集、 Tau蛋白磷酸化和神经炎症
Mol Biol Rep. 2025 Jan 31;52(1):183. doi: 10.1007/s11033-025-10284-x.
3
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease.长非编码 RNA 在阿尔茨海默病发病机制中的新兴作用。
Ageing Res Rev. 2019 Mar;50:19-26. doi: 10.1016/j.arr.2019.01.001. Epub 2019 Jan 2.
4
Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease.挖掘长链非编码RNA在阿尔茨海默病病理生理学中的潜力。
Exp Neurol. 2025 Mar;385:115134. doi: 10.1016/j.expneurol.2024.115134. Epub 2024 Dec 29.
5
Insights into lncRNAs in Alzheimer's disease mechanisms.阿尔茨海默病机制中长链非编码 RNA 的研究进展。
RNA Biol. 2021 Jul;18(7):1037-1047. doi: 10.1080/15476286.2020.1788848. Epub 2020 Jul 14.
6
Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer's Disease.探索非编码RNA在阿尔茨海默病中的治疗潜力。
Protein Pept Lett. 2024;31(11):862-883. doi: 10.2174/0109298665335550241011080252.
7
The Role of Non-coding RNAs in Alzheimer's Disease: Pathogenesis, Novel Biomarkers, and Potential Therapeutic Targets.非编码 RNA 在阿尔茨海默病中的作用:发病机制、新型生物标志物和潜在治疗靶点。
CNS Neurol Disord Drug Targets. 2024;23(6):731-745. doi: 10.2174/1871527322666230519113201.
8
Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer's disease.某些长链非编码 RNA 在阿尔茨海默病中作用的分子机制。
Metab Brain Dis. 2020 Jun;35(5):681-693. doi: 10.1007/s11011-020-00564-9. Epub 2020 Mar 17.
9
Long Non-Coding RNAs and Alzheimer's Disease: Towards Personalized Diagnosis.长非编码 RNA 与阿尔茨海默病:迈向个体化诊断。
Int J Mol Sci. 2024 Jul 11;25(14):7641. doi: 10.3390/ijms25147641.
10
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.非编码RNA作为阿尔茨海默病神经炎症的新型调节因子
Front Immunol. 2022 Jun 2;13:908076. doi: 10.3389/fimmu.2022.908076. eCollection 2022.

引用本文的文献

1
Lead Induces Mitochondrial Dysregulation in SH-SY5Y Neuroblastoma Cells via a lncRNA/circRNA-miRNA-mRNA Interdependent Networks.铅通过长链非编码RNA/环状RNA-微小RNA-信使核糖核酸相互依赖网络诱导SH-SY5Y神经母细胞瘤细胞线粒体功能失调。
Int J Mol Sci. 2025 Jul 17;26(14):6851. doi: 10.3390/ijms26146851.
2
Cannabinerol Restores mRNA Splicing Defects Induced by β-Amyloid in an In Vitro Model of Alzheimer's Disease: A Transcriptomic Study.大麻二酚在阿尔茨海默病体外模型中恢复由β-淀粉样蛋白诱导的mRNA剪接缺陷:一项转录组学研究
Int J Mol Sci. 2025 Mar 28;26(7):3113. doi: 10.3390/ijms26073113.

本文引用的文献

1
Tanshinone IIA improves Alzheimer's disease RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis.丹参酮IIA改善阿尔茨海默病RNA核富集丰富转录本1/微小RNA-291a-3p/RAS癌基因家族成员Rab22a轴。
World J Psychiatry. 2024 Apr 19;14(4):563-581. doi: 10.5498/wjp.v14.i4.563.
2
Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.长链非编码 RNA UCA1 在阿尔茨海默病中的诊断价值和认知调节作用。
Neurosci Lett. 2024 Apr 23;829:137765. doi: 10.1016/j.neulet.2024.137765. Epub 2024 Apr 5.
3
LINC00472 Regulates Ferroptosis of Neurons in Alzheimer's Disease via FOXO1.
LINC00472 通过 FOXO1 调控阿尔茨海默病神经元中的铁死亡。
Dement Geriatr Cogn Disord. 2024;53(3):107-118. doi: 10.1159/000537883. Epub 2024 Apr 4.
4
Mechanisms underlying LncRNA SNHG1 regulation of Alzheimer's disease involve DNA methylation.LncRNA SNHG1 调控阿尔茨海默病的机制涉及 DNA 甲基化。
J Toxicol Environ Health A. 2024 May 18;87(10):428-435. doi: 10.1080/15287394.2024.2334248. Epub 2024 Mar 29.
5
Inhibitory effects of β-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer's disease.β-细辛醚对阿尔茨海默病模型中lncRNA BACE1介导的自噬诱导的抑制作用
Behav Brain Res. 2024 Apr 12;463:114896. doi: 10.1016/j.bbr.2024.114896. Epub 2024 Feb 4.
6
Combining Multifunctional Delivery System with Blood-Brain Barrier Reversible Opening Strategy for the Enhanced Treatment of Alzheimer's Disease.多功能递药系统与血脑屏障可逆开放策略联合用于增强阿尔茨海默病的治疗。
Adv Healthc Mater. 2024 Mar;13(8):e2302939. doi: 10.1002/adhm.202302939. Epub 2023 Dec 26.
7
LncRNA ENST00000440246.1 Promotes Alzheimer's Disease Progression by Targeting PP2A.长链非编码RNA ENST00000440246.1通过靶向蛋白磷酸酶2A促进阿尔茨海默病进展。
Biochem Genet. 2024 Jun;62(3):2100-2116. doi: 10.1007/s10528-023-10552-0. Epub 2023 Oct 19.
8
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.MEG3 激活人神经元异种移植物模型中的坏死性凋亡。
Science. 2023 Sep 15;381(6663):1176-1182. doi: 10.1126/science.abp9556. Epub 2023 Sep 14.
9
Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD : The Role of Dexmedetomidine in AD.右美托咪定通过抑制 lncRNA SNHG14/UPF1 轴促进 HSPB8 表达抑制 AD 神经细胞凋亡:右美托咪定在 AD 中的作用。
Neurotox Res. 2023 Oct;41(5):471-480. doi: 10.1007/s12640-023-00653-4. Epub 2023 Sep 1.
10
Triptolide improves Alzheimer's disease by regulating the NF‑κB signaling pathway through the lncRNA NEAT1/microRNA 361‑3p/TRAF2 axis.雷公藤甲素通过lncRNA NEAT1/微小RNA 361-3p/TRAF2轴调控NF-κB信号通路来改善阿尔茨海默病。
Exp Ther Med. 2023 Aug 1;26(3):440. doi: 10.3892/etm.2023.12139. eCollection 2023 Sep.